Minority Resident Hematology Award Program

The ASH Minority Resident Hematology Award Program (MRHAP) provides hematology research support for resident students who come from communities underserved and underrepresented in hematology in the United States and Canada. Through the MRHAP, which is part of the ASH Minority Recruitment Initiative, trainees are matched with and receive guidance from a career-development mentor, gain valuable knowledge of hematology, and ultimately, advance their careers. Learn more about the program benefits.

Individuals from the following groups are encouraged to apply:

• Medical residents, including Minority Medical Student Award Program alumni who are enrolled in an internal medicine, pathology, or pediatric residency program.
• Resident physicians who have applied to or matched early into a hematology-oncology fellowship program.

Please note that applicants must have a research mentor who is an ASH member in good standing and must be within the first two years of a residency program.

The following ASH-Roland B. Scott Minority Resident Hematology Award is also part of the MRHAP program:

ASH-Roland B. Scott Minority Resident Hematology Award
The ASH-Roland B. Scott Award, named for the late Roland B. Scott, MD, is an award that honors Dr. Scott’s legacy and pioneering contribution to sickle cell disease research.

Roland B. Scott, MD, was an American pediatrician and internationally known researcher known for his work on Sickle Cell Disease (SCD) and his advocacy on behalf of patients impacted by the illness. Despite not being a hematologist, in 1948 Dr. Scott published a report on the incidence of red cell sickling in newborn infants which helped to change the modern understanding of the disease and would eventually lead to the implementation of newborn screening tests that are now standard practice.

In addition to conducting research and treating patients, Dr. Scott led other physicians in lobbying Congress to pass the Sickle Cell Anemia Control Act of 1971, which provides federal funding for research and treatment of the disease. After the Act’s passage, Dr. Scott opened the Howard University Center for Sickle Cell Disease in 1972 and remained its Director until his retirement in 1990. Until his death in 2002, Dr. Scott was frequently cited as the premier authority on sickle cell diseases.

The ASH-Roland B. Scott Award recognizes the highest-scoring MRHAP award recipient whose research project is focused on Sickle Cell Disease. The award provides a $16,000 stipend to support their research, $2,000 for mentor research supplies, and an additional $2,000 for travel to the annual meeting.

Key Dates

Questions?

For questions about the ASH Minority Resident Hematology Award Program or requests for additional information, please contact [email protected].

For information about supporting the award, contact the Corporate Relations team at [email protected] or 202-776-0544.

Never miss an important deadline—sign up to receive email updates about ASH awards and training programs.

Get email updates